Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose (Q35932315)

11 August 2017

Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose (English)

1 reference

11 August 2017

1 reference

5

Josiah D Rich

1 reference

11 August 2017

Michael A Yokell

1

1 reference

11 August 2017

Nickolas D Zaller

series ordinal

2

1 reference

11 August 2017

Traci C Green

series ordinal

3

1 reference

11 August 2017

Michelle McKenzie

series ordinal

4

1 reference

11 August 2017

1 January 2012

1 reference

Journal of Opioid Management: a medical journal of proper and adequate use

11 August 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 August 2017

8

1 reference

11 August 2017

1

1 reference

11 August 2017

63-66

1 reference

Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

A flood of opioids, a rising tide of deaths

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Opioid formulations designed to resist/deter abuse

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Evaluation of a naloxone distribution and administration program in New York City

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Heroin overdose: causes and consequences

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Serious overdoses involving buprenorphine in Helsinki

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3343634

Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22479887

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5055/JOM.2012.0098

1 reference

11 August 2017

1 reference

11 August 2017

1 reference